::CURRICULAM : Phase II MBBS : UG TIMETABLE (2020-2021)
  PATHOLOGY MICROBIOLOGY PHARMACOLOGY INTEGRATION
MARCH – APRIL 2021 THEORY Theory - General Bacteriology THEORY(12 hours)
The principles of pharmacology (PH1.1) nomenclature of drugs (PH 1.9) routes of drug administration (SDL-1h)(PH 1.11)  drug formulations and drug delivery Systems.(PH1.3)absorption, distribution, metabolism & excretion of drugs.(PH 1.4) mechanism of drug action.(PH 1.5) Evidence based medicine and Therapeutic drug monitoring.(PH 1.2) drug interactions(PH1.8) adverse drug reactions (ADR).(PH 1.7)
Parts of a correct, complete and legible generic prescription. (PH1.10)
Principles of Pharmacovigilance & ADR reporting system . (SDL- 2h) (PH1.6)
dosage of drugs for an individual patient, children, elderly and patient with renal dysfunction (PH 1.12)
Drug dosages (SDL-2h) Steps in new drug development(SDL-2h) PRACTICALS
Terms in pharmacology(SDL- 1h)
Sources of drugs(SDL-1h)
 
Introduction to Pathology  
(PA1.1- 1.3) Introduction & History (1)
AETCOM - Bioethics (module 2.2) Morphology & Physiology of
Common definitions and terms used Bacteria (2)
in pathology(PA 1.2)(SDL- 1hr) General properties of Viruses &
cell injury & cellular adaptations Virus Host Interaction (3)
(PA2.1- 2.7) Introduction to Mycology (1)
Hemodynamic disorders Introduction to Parasitology (1)
( PA6.1- 6.6) Different Causative agents &
  epidemiological basis of ID’s &
PRACTICALS detection methods (2) ( MI-1.1#) &
  ( MI-1.3)
Identify and describe various forms Sterilization & Disinfection (2)
of cell injuries, their manifestations ( MI -1.4*)
and consequences in gross and  
microscopic specimens (PA2.8) Practical
Identify and describe the gross and Microscopy &
microscopic features of infarction Morphology of Bacteria (2) ( MI-
and thrombus in a pathologic 1.2 #)
specimen ( PA6.4, 6.7) Grams Stain - D (2) ( MI-1.2 #)
  Sterilization & Disinfection in
  Clinical & Surgical Practice (1)
  ( MI-1.5 ) – SGD /T
  Culture Media & Methods (2) - SGD
  /T
 
 
      Drug dosage forms
*Bio-ethics(AETCOM) -
HUMAN
Clinical pharmacology charts 10
(SGD)
Qualitative chart 1 (SGD)
*OSPE (AETCOM)
 
APRIL-MAY 2021 THEORY Theory - Immunology THEORY -ANS
Neuro humoral transmission Cholinergic system & drugs Anti- cholinergic drugs Adrenergic system & drugs
Anti adrenergic drugs , Drugs for glaucoma Drugs acting on Autonomic Ganglion( PH 1.13 - 1.14)
 
AUTOCOIDS
Histamine & antihistamine 5HT and its Antagonists and Drug Therapy Of Migraine
Prostaglandins, Leukotrienes and PAF NSAIDS Antirheumatoid and Anti Gout Drugs.(PH 1.16) Laboratory animals (SDL-1hr) PRACTICAL -ANS
Clinical pharmacology charts:
(SGD)
Qualitative charts – Ex. No.: 1,2,3,5,9,10 (SGD)
Experimental pharmacology charts: Ex. No.: 1,2,3,4,5,6 (SGD)
Problem solving exercise : ex.no.:1,2 (SGD)
Dosage calculation : Ex.no.:1,2 Toxicology charts: Ex.no.:1,2,3.
 
Inflammation (PA4.1-4.4) Antibiotics, Mechanism of action and
Healing & repair (PA5.1) drug resistance and monitoring
Environmental and nutritional antimicrobial therapy (2) MI-1.6*
diseases ( PA 12.1-12.3) Bacterial Genetics (1)
Pathogenesis of disorders caused by Infections – Classification, Sources
air pollution, tobacco, and & Mode of Transmission, Microbial
alcohol(PA 12.1)(SDL- 1hr) Pathogenicity & Types of ID (2)
  (MI-1.1#)
  Structure of Immune System (1)
  Immunity (1) MI-1.7
  Antigen, Antibody & Complement
PRACTICALS (2)
Identify and describe acute and Immune Response (2) (MI-1.8#)
chronic inflammation in gross and Immune Evasion by Pathogen (1)
microscopic specimens (PA4.4) (MI-1.8#)
  Practical
  Grams Staining OA (4) (M-1.2#)
  Biochemical Identification (1)
  – SGD /T
  AST methods (1) ( MI-1.6) – SGD /T
  Antigen & Antibody Reaction-SGD
  (2)
 
 
       
AUTACOIDS
Problem solving exercise : ex.no.:6,7 (SGD)
Pharmacoeconomics:Ex.no.: 1 ADR reporting : Ex.no.: 1 (Page no.:259) (SGD)
Toxicology charts: Ex.no.: 7 Bio-ethics(AETCOM) ANIMAL
*OSPE (AETCOM)
 
MAY-JUNE 2021 THEORY
Immunopathology PA 9.1- 9.3, 9.7)
Amyloidosis( PA3.1-3.2) Principles and mechanism involved in immunity(PA 9.1)(SDL-1hr) AETCOM - Working in a health care team - role of pathologist in patients care (module 2.4)
 
PRACTICALS
Identify and describe amyloidosis in a pathology specimen ( PA 3.2)
Theory – Immunology
 
Immune Evasion by Pathogen (1) (MI-1.8#)
Vaccines (1) ( MI-1.9) Immunological Disorder (HS, AID & ID) (3) (MI-1.10*)
Tumor & Transplantation Immunity (1) (MI-1.11)
 
Practical
 
Grams Staining P (4) ( MI 1.2#) Detection Methods of immunological Disorder (2) MI-1.10
THEORY PNS
Skeletal muscle relaxant(PH 1.15)
Local anaesthetics (PH 1.17) MISCELLANEOUS
Management of common poisoning, insecticides, common sting and bites(PH1.52)
heavy metal poisoning and chelating agents (PH1.53) Vaccines, Antiseptics And Disinfectants, Environmental Toxicants((PH1.51,1.54,1.62)
Enzymes In Therapy, Therapeutic Gases
Drug Interactions(PH1.60) Paediatric And Geriatric Pharmacology(PH1.56) Vitamins , Antioxidants, dietary supplements and nutraceuticals(PH1.61)
Laws pertaining to Pharmacology(SDL-2h)
 
PRACTICALS
AUTOIMMUNITY & SLE (PA 9.4 - 9.5)
Microbiology(MI1. 10)
General medicine
 
AIDS (PA 9.6)
Microbiology(MI- 1.10) ,
General medicine
 
 
      Clinical pharmacology charts:
(SGD)
Qualitative charts – Ex. No.: 4(SGD)
Dosage calculation : Ex.no.:6,7
*Computer Assisted Learning(CAL)- animal experiment
*OSPE (AETCOM)
 
JUNE –JULY 2021 THEORY
Pathogenesis and pathology of cysticercosis & common bacterial, viral, protozoal and helminthic diseases
( PA 10.2 - 10.4)
NEOPLASTIC disorders (PA7.1– 7.5)
Basic diagnostic cytology PA 8.1-8.3)
AETCOM - Health care as a right (module 2.3)
 
 
PRACTICALS
Demonstration of Malarial parasites (PA10.1)
DEMONSTRATION
Gross & microscopy to differentiate between benign from malignant neoplasm (PA7.1)
 
Identify and describe gross specimen & microscopic appearanceof tuberculosis (PA 26.4)
Theory - CNS Infections
 
Meningitis – Bacterial, Viral , Fungal & Protozoal (3) ( M1-5.1) Encephalitis , Brain Abscess, SOL, Parasitic CNS infections, Slow viral diseases & Rabies (7)
 
Practical
 
Microbial Agents Causing Meningitis DOAP (2) (MI – 5.3) ZN Stain D (2) (MI-1.2#)
Specimen Collection & Transport (2) ( MI-8.9#)
Specimen Processing (2) ( MI-8.9#)
THEORY ANTIMICROBIAL DRUGS
General Considerations(PH1.42,1.43) Sulfonamides Fuoroquinolones
Beta Lactam Antibiotics Aminoglycosides Macrolide, Lincosamide, Glycopeptide
 
Antituberculous Drugs(PH1.44,1.45)
Antileprotic Drugs(PH1.46) Antifungal Drugs
 
Antiviral Drugs(PH1.49) Antimalarial Drugs(PH1.47,1.55) Antiamoebic Drugs(PH1.47,1.55)
Other Protozoal Drugs(PH1.47,1.55)
 
Antihelminthic Drugs(PH1.47,1.55)
 
PRACTICALS
Define and describe the pathogenesis and pathology of malaria (PA10.1) Microbiology(MI 5.1)
Pharmacology (PH 1.47,1.55)
 
 
 
 
Define and describe the etiology, types, pathogenesis, stages,
morphology and complications of tuberculosis(PA26. 4)
Microbiology (MI- 6.1) &
Pharmacology
 
 
      Prescription writing : Ex.no.:9,10,13,14
Prescription audit : Ex.no.:10 Dosage calculation : Ex.no.:10 Pharmacoeconomics:Ex.no.:5,6,7,8, 9,10
ADR reporting : Ex.no.:1,3 (SGD) Problem solving exercise : ex.no.:10,11,12 (SGD)
*Computer Assisted Learning(CAL) – animal experiment
*OSPE (AETCOM)
 
JULY-AUGUST THEORY Theory - CVS & Blood THEORY BLOOD
Haematinics And Erythropoietin(PH 1.35)
Drugs affecting Coagulation (PH 1.25)
Plasma expanders(PH 1.25) Hypolipidemic Drugs . (PH 1.31) Diuretics
Anti-diuretics. (PH 1.24)
 
Anticancer Drugs(PH1.49,1.55) Immunomodulator Drugs(PH1.50)
 
CARDIOVASCULAR SYSTEM
Renin Angiotensin System.(PH 1.26)
Cardiac Glycosides Antiarrythmic Drugs.(PH 1.30)
Antianginal Drugs(PH 1.28) Antihypertensive Drugs Shock (PH 1.27) PRACTICAL
Interpret abnormalities in cardiac function testing in acute coronary syndromes (PA27.8)
Physiology
2021    
  Cardiovascular system RF & Infective Endocarditis (1)
  (PA27.1-27.10) (MI- 2.1 & 2.2)
    Staphylococcus & CoNS (1)
  Introduction to haematology ( PA Streptococcus (1)
  13.1-13.4) Enterococcus / HACEK (1)
  Define and classify Anaemia (1) (MI – 2.4)
  anemia(PA13.3)(SDL-1hr) Malaria, Kalaazar, Filaria (3) (MI-
  ANAEMIA 2.5)
  (14.1,14.2,15.1,15.2,15.4,16.1-  
  16.5,17.1,17.2) Practical
  Metabolism of Vitamin B12 and  
  etiology and pathogenesis of B12 ZN Stain (4) OA (MI – 1.2 #)
  deficiency(PA15.1)(SDL-Ihr) Identification of Microbes causing
  Define and classify hemolytic RHD & IE (1) ( MI - 2.3)
  anemia(PA16.1)(SDL-1hr) Malaria & Filaria / L & T (2) MI
  Hemorrhagic disorders (PA21.1- 2.6
  21.5) PUO (1) - SGD / T
  Describe normal  
  hemostasis(PA21.1)(SDL-1hr)  
  Leukocyte disorders , Lymph nodes  
  & spleen(PA18.1,18.2,  
  19.1,19.2,19.4,19.6)  
 
 
  Describe the causes of leucocytosis, leucopenia, lymphocytosis, and leukemoid reactions(PA18.1)
(SDL-1hr)
Plasma cell disorders (PA20.1) AETCOM - Bioethics - autonomy and decision making (module 2.5) Lymphnode biopsy - revealing the diagnosis to the patient
 
 
PRACTICALS
Identify and describe gross specimens of fibrinous pericarditis, atheroma aorta, left ventricular hypertrophy  ( PA 27.1,27.4,27.9)
 
Identify and describe the features of tuberculous lymphadenitis, Hodgkin lymphoma in a gross and microscopic specimen (PA 19.3, 19.5)
Identify and describe the gross specimen of an enlarged spleen (PA 19.7)
Plasma cell disorders (PA20.1)
  Clinical pharmacology charts:
(SGD)
Qualitative charts – Ex. No.: 7,8
(SGD)
Prescription writing : Ex.no.:3,4,5,6 Prescription audit : Ex.no.:4,5,6 Dosage calculation : Ex.no.:3,8 Pharmacoeconomics:Ex.no.:2,3 ADR reporting : Ex.no.:4 (SGD) Toxicology charts: Ex.no.:8 Toxicology charts: Ex.no.:9 Problem solving exercise : ex.no.:9 (SGD)
ADR reporting : Ex.no.:5 (SGD)
*OSPE (AETCOM)
*Computer Assisted Learning(CAL) – animal experiment
 
AUGUST- SEPTEMBER 2021 THEORY
Respiratory system
(PA 26.2,26.3,26.5-26.7)
Genetic and paediatric diseases (PA11.1-11.2)
 
PRACTICALS
Identify and describe gross
specimens of bronchiectasis, pneumonia, and carcinoma lung (
Theory - Respiratory Tract Infections
URTI & LRTI including atypical pneumonia's and lung abscess (12) (MI-6.1)
 
Practical
ZN Stain (3) P ( MI -1.2#)
Etiological agents of URI & LRI (2) (MI 6.2 & 6.3)
THEORY RS
Drugs for bronchial asthma Drugs for COPD
Drugs for Cough ( PH 1.32, 1.33)
 
CNS
Introduction to CNS Alcohols
Sedative & hypnotics
common storage disorders in infancy and childhood (PA11.3)
Paediatrics
 
Bronchial asthma (Pathology 26.3 & Pharmacology PH 1.32)
 
 
  PA 26.3,26.1,26.6)
 
Identify and describe the microscopic appearance of pneumonia (26.1)
Demonstrate respect for patient samples received in lab
(1) ( MI- 8.11) (AETCOM) Demonstrate appropriate method of collection & performance of lab test (1) ( MI - 8.10)
Demonstrate confidentially pertaining to patient identity
(1) ( MI -8.14) (AETCOM) Interpretation of lab Results (1) SGD ( MI -8.15)
Anti- Psychotics
Anti – manics , Anti-depressants , Anti- anxiety.
(PH 1.18 -1.20) Drug abuse &
addiction(PH 1.19 , 1.21 -1.23)
 
PRACTICAL RS
Prescription writing : Ex.no.: 7,8 Prescription audit : Ex.no.: 8 CNS - PSYCHIATRY
Experimental pharmacology charts: Ex. No.: 2 (SGD)
Toxicology charts: Ex.no.:4,5 Problem solving exercise : ex.no.:3,4 (SGD)
*OSPE (AETCOM)
*Computer Assisted
Learning(CAL) – animal experiment
 
Define and describe the etiology, types, pathogenesis, stages, morphology complications and treatment of pneumonia
(PA 26.1) MICROBIOLOGY(MI 6.1)
Pharmacology
SEPTEMBER
-OCTOBER 2021
THEORY
Gastrointestinal tract (PA 24.1, 24.2,24.4-24.7)
Hepatobiliary system (PA25.1-25.5) Bilirubin metabolism, etiology, and pathogenesis of jaundice, distinguish between direct and indirect hyper- bilirubinemia(PA25.1)(SDL-1hr)
 
CNS (PA 35.1- 35.3)
 
 
 
 
PRACTICALS
Describe and identify the microscopic features of peptic ulcer & tuberculous intestine (PA 24.3,24.5)
Identify and describe the features of
Theory - GIT & Hepatobiliary System
Diarrhoea & dysentery (2) (MI-3.1) Enteric Fever (1) (MI-3.3)
Food Poisoning – Viral, Vibrio, E.coli, Campylobacter, Yersinia (3) (MI-3.5)
APD & Hepatitis (3) ( MI - 3.6 & 3.7)
 
Practical
Etiological Agents of diarrhea & Dysentery (2) (MI-3.2)
Enteric Fever diagnosis(1)DOAP (MI- 3.4)
Viral hepatitis Markers(1) (MI-3.8) Stool Examination (2) D ( MI -1.2#)
THEORY
CNS continued General anaesthetics Anti- epileptics
Anti- parkinsonian drugs Opiod analgesics
CNS Stimulants GIT
Drugs For Peptic Ulcer Antiemetics And Prokinetics Antidiarrheal Drugs And Drugs For Constipation (PH 1.34) PRACTICAL
CNS
Experimental pharmacology charts: Ex. No.: 1 , 2 (SGD)
Prescription writing : Ex.no.:1,2, Prescription audit : Ex.no.:1,2,3
Viral hepatitis (PA 25.3)
MICROBIOLOGY(
MI 3.7) & General medicine
 
 
  cirrhosis liver in a gross and microscopic specimen (PA25.4) DOAP
Interpret liver function and viral hepatitis serology panel.
Distinguish obstructive from non- obstructive jaundice based on clinical features and liver function tests (PA 25.6)
Identify the etiology of meningitis based on given CSF
parameters (PA35.3)
  ADR reporting : Ex.no.:2 (SGD) Toxicology charts: Ex.no.:6 Problem solving exercise : ex.no.:5 (SGD)
GIT
Prescription writing : Ex.no.: 11,12 Prescription audit : Ex.no.: 9 Pharmacoeconomics:Ex.no.: 4
*OSPE (AETCOM)
*Computer Assisted Learning(CAL) – animal experiment
 
OCTOBER
–NOVEMBER 2021
THEORY
Urinary Tract (PA 28.1-28.11) Male Genital Tract (PA 29.1- 29.5)
Female Genital Tract (PA 30.1 - 30.9) Normal histology of kidney(PA 28.1)(SDL-1 hr)
Classification of testicular tumors(PA29.1) and OVARIAN TUMORS( 30.4)(SDL-1hr)
 
PRACTICALS
Identify and describe the features of tumors of kidney in a gross and microscopic specimen (PA 28.14) Identify gross appearance of renal & vesical stones (PA 28.13)
Theory - Genitourinary & STD Infections
Etiopathogenesis of Genitourinary Tract Infections (1) ( MI-7.1) Etiological agents of STI - Bacterial, viral & parasitic (4) (MI-7.2#)
UTI - causes & laboratory diagnosis (1) ( MI-7.3)
Practical
Diagnosis of Syphilis (1) (MI -7.2#)
Stool Examination (4) OA ( MI -1.2#)
Parastiology Slides (3) T Miscellaneous & uncovered important bacteria's(SGD)(3)
THEORY HORMONES
Introduction Androgens
Estrogen, progestin and contraceptive
Oxytocin and drugs acting on uterus
 
PRACTICAL
Problem solving exercise : ex.no.:8
(SGD)
Prescription audit : Ex.no.: 7 Dosage calculation : Ex.no.: 6 ,7
*OSPE (AETCOM)
*Computer Assisted
Learning(CAL) – animal experiment
Carcinoma cervix (PA 30.1)
Obstetrics & gynaecology
NOVEMBER THEORY Theory - Skin & Soft Tissue THEORY Thyroid metabolic
- DECEMBER 2021 Breast ( PA 31.1,31.2,31.4)
Endocrine system ( PA 32.1-32.9) Classify and describe the etiology, pathogenesis and iodine dependency of thyroid swellings(PA32.1)(SDL-1hr)
Bone & soft tissue (PA 33.1-33.5) Skin ( PA 34.1- 34.3)
Infections
Anaerobic Infections (1) (MI- 4.1) Bone & Joint Infections (1) (MI- 4.2) Skin & soft infections MI4.3 (Bacterial, viral, fungal & Parasitic
(8) MI 4.3
HORMONES
Anterior Pituitary Hormones Thyroid hormones
Insulin, oral hypoglycemic drugs and glucagon
Drugs affecting calcium balance
disorders (PA 32.1-
32.3)
Physiology Pharmacology
  Eye ( PA 36.1) Common Parasitic infections (1) MISCELLANEOUS  
    Common Viral infections (1) Drugs Acting On Skin, Treatment  
 
 
  PRACTICALS
Describe and identify the morphologic and microscopic features of carcinoma of the breast (PA 31.3)
 
Identify, distinguish and describe common tumors of the skin (PA 34.4)
Practical
Stool Examination (3) P ( MI -1.2#) Fungal Culture & Slides (3) on PPE, Hand Hygiene & BMW DOAP(3)
Of Scabies, Drugs For Psoriasis, Drugs For Acne Vulgaris (PH1.57) (SGD)
*OSPE (AETCOM)
*Computer Assisted
Learning(CAL) – animal experiment
 
 
 
Small Group Teaching ( Microbiology) March 15th– July 14th  
  Day(1) Day(2) Day(3) Day(4) Day(5)
1st Causative agents of Zoonotic Yersinia, Tularemia & Leptospira (MI -8.1#) Brucella (MI -8.1#) Discussion
Week Diseases & Anthrax (MI - Pasteurella (MI -8.1#)      
  8.1#)        
2nd Opportunistic Infections in Infections in Burns infections Oncogenic viruses Discussion
Week HIV &
immunocompromised(MI -
Neutropenics &
Transplant recipient
(MI -8.2#) (MI -8.3)  
  8.2#) (MI -8.2#)      
3rd Emerging     & Reemerging
Infections (MI -8.4)
Chlamydia Rickettsiae Hemorrhagic fever Discussion
Week        
4th HAI (MI -8.5) Basis     of             Infection Surveillance of air, National Health Discussion
    control (MI -8.5) water & food     Programmes    
Week     (MI -8.6)     (MI -8.16)    
Integration  Topics(12 hours)  
  HIV TB Malaria Hepatitis Immunopathology Pneumonia
   
Self-Directed Learning (10 hours )
   
                     
 
  WHO / CDC NACO NCDC VBDC TBC INDIA  
  NHM Reference Centre –
Various Infectious Diseases
NVHSP Automation in Microbiology Molecular
Techniques in Microbiology
 
 
Small Group Discussion (14 hours)
1.Sterilisation and Disinfection in clinical practice(1 hr) 2.Culture Media & Methods ( 1 hr)
3.Biochemical Identification (1hr) 4.AST Methods (1)
  1. PUO (1hr)
  2. Interpretation of Lab results (1 hr)
  3. Etiological agents causing Anaemia, Morphology, Pathogenesis, Lab diagnosis and treatment (2 hrs) 8.Antigen Antibody reactions (2 hrs)
9.Miscellaneous and uncovered bacterias(3 hrs)
 
 
 
DOAP 47 hours
Grams stain – D (MI1.2#)(2) Gramstain-OA(M1.2#)(4)
 
Gram staining P (M11.2#)(4) Microscopy (MI1.2#)(2)
Microbial agents causing Meningitis (MI-5.3#)(2) ZN stain-MI(1.2#)(2)
ZN Stain OA(MI-1.2#)(4) ZN Stain-P(MI-1.2#)(3)
Identification of Microbes causing RHD &IE (MI2.3)(2) Malaria/Filaria /L&T (MI 2.6)(2)
Etiological agents of URI &LRI(MI 6.2&6.3)(2)
Demonstrate appropriate Method of collection &performance of lab test (MI-8.10)(1) Etiological agents of Diarrhoea & Dysentry (MI 3.2)(2)
Enteric Fever Diagnosis (MI-3.4)(1) Stool examination D (MI1.2#)(2) Stool examination OA (MI1.2#)(4) Stool Examination P (MI1.2#)(3)
Hand hygiene ,PPE&BMWM (MI8.7)(7)
Others-17 hours including OSPE , Problem based learning, Case scenario ,slides AETCOM -5 hours
 
 
 
SMALL GROUP TEACHING - PATHOLOGY ( April - September)
 
WEEK 1 DAY 1 DAY 2 DAY 3 DAY 4 DAY 5
  Describe the peripheral blood picture in anemias (PA13.5, 14.3,
15.3,16.6)
PRACTICALS
Prepare a peripheral blood smear and identify anaemia (PA13.5, 14.3,
15.3,16.6)
 
PRACTICALS
Prepare a peripheral blood smear and identify anaemia (PA13.5, 14.3,
15.3,16.6)
 
 
Hemoglobin estimation
 
 
PRACTICALS
Hemoglobin estimation
WEEK 2 DAY 1 DAY 2 DAY 3 DAY 4 DAY 5
  Blood banking and transfusion (22.1-22.7) Blood grouping & RH typing (PA22.1) PRACTICALS
Blood grouping & RH typing (PA22.1)
 
Clinical Pathology (PA23.2,22.3)
Describe the correct technique to perform a cross match (16.7) Describe abnormal urinary findings in disease states and identify and describe common urinary abnormalities in a clinical specimen (PA23.1)
WEEK 3 DAY 1 DAY 2 DAY 3 DAY 4 DAY 5
  PRACTICALS
Urine examination
PRACTICALS
Urine examination
SLIDE DISCUSSION SLIDE DISCUSSION SLIDE DISCUSSION
WEEK 4 DAY 1 DAY 2 DAY 3 DAY 4 DAY 5
  Gross
specimens 1st semester
Gross specimens
discussion 2 nd semester
Gross specimens
discussion 2 nd semester
Wet specimens discussion Charts discussion
 
 
SELF DIRECTED LEARNING: (12 HRS)
 
  1. Common definitions and terms used in pathology(PA1.2) (1hr)
 
  1. Pathogenesis of disorders caused by air pollution ,tobacco and alcohol(PA12.1)(1hr)
 
  1. Principles and mechanism involved in immunity(PA9.1)(1hr)
 
  1. Metabolism of vitamin B12 and etiology and pathogenesis of B12 deficiency(PA15.1)(1hr) 5.Define and classify hemolytic anemia(PA 16.1)(1hr)
  1. Describe normal hemostain(PA21.1)(1hr)
 
  1. Describe the causes of leucocytosis, leucopenia,lymphocytosis and leukemoid reaction(PA18.1)(1hr)
 
  1. Bilirubin metabolism, etiology and pathogenesis of jaundice.Distinguish between direct and indirect hyperbilirubinemia(PA25.1)(1hr) 9.Normal histology of kidney(PA28.1)(1hr)
10.Classification of testicular tumour (PA29.1) and ovarian tumour((PA30.4)(1hr) 11.Define and classify anemia(PA13.3)(1hr
12.Classify and describe the etiology ,pathogenesis and iodine dependency of thyroid swellings(PA32.1)(1hr)
 
 
 

INTEGRATION TOPICS: (12 hours)

 
1.Autoimmunity and SLE(PA9.4 - 9.5)(1hr) 2.AIDS(PA9.6)(1hr
  1. Malaria (PA10.1) (1 hr)
 
  1. Tuberculosis(PA26.4)(2 hr)
 
  1. Cardiac functioning test in acute coronary syndromes(PA27.8)( 1 hr)
 
  1. common storage disorders in infancy and childhood (PA11.3)(1 hr) 7.Bronchialasthma (PA26.3)(1 hr)
8.pneumonia(26.1)(1HR) 9.Viral hepatitis (PA 25.3)
  1. carcinoma cervix (PA30.1)(1hr)
 
  1. thyroid metabolic disorders (PA32.1-32.3) (1hr)
 
 
 

SMALL GROUP DISCUSSION : (56 HRS)

 
  1. Describe the peripheral blood picture in anemias (PA13.5, 14.3, 15.3,16.6)
 
  1. Hemoglobin estimation
 
  1. Blood banking and transfusion (22.1-22.7)
 
  1. Blood grouping & RH typing (PA22.1)
 
  1. Describe the correct technique to perform a cross match (16.7)
 
  1. Describe abnormal urinary findings in disease states and identify and describe common urinary abnormalities in a clinical specimen (PA23.1)
 
  1. Gross specimens discussion
 
  1. Wet specimens discussion 9.OSPE Charts discussion
10. Slide discussion
 
 
 

DOAP: (36hrs)

 
  1. Prepare a peripheral blood smear and identify anaemia (PA13.5, 14.3, 15.3,16.6)
 
 
  1. Hemoglobin estimation
 
  1. Blood grouping & RH typing (PA22.1)
 
  1. Urine examination
 

SMALL GROUP DISCUSSIONS – PHARMACOLOGY

 
MONTH WEEK 1 WEEK 2 WEEK 3 WEEK 4
 
MARCH
Clinical pharmacology charts Clinical pharmacology charts Clinical pharmacology charts  
Qualitative chart
 
APRIL
Clinical pharmacology charts  
Qualitative chart
Experimental pharmacology charts Problem solving exercises
 
MAY
Clinical pharmacology charts  
Qualitative chart
Clinical pharmacology charts  
Qualitative chart
 
JUNE
ADR reporting Problem solving exercises ADR reporting Problem solving exercises
 
JULY
Clinical pharmacology charts  
Qualitative charts
Experimental pharmacology charts  
Problem solving exercises
 
AUGUST
Experimental pharmacology charts Experimental pharmacology charts  
Problem solving exercises
 
Problem solving exercises
 
SEPTEMBER
Experimental pharmacology charts Experimental pharmacology charts Problem solving exercises  
ADR reporting
 
OCTOBER
Problem solving exercises Problem solving exercises Problem solving exercises Problem solving exercises
NOVEMBER Drugs Acting On Skin Treatment Of Scabies Drugs For Psoriasis Drugs For Acne Vulgaris
 

PHARMACOLOGY

 
 
 
SELF DIRECTED LEARNING: (12 HRS)
 
  1. Pharmacovigilance (2 hrs)
  2. Drug dosages (2 hrs)
  3. Various sources of drugs (1 hr)
  4. Routes of drug administration (1 hr)
  5. Terms in Pharmacology (1 hr)
  6. Laws pertaining to Pharmacology (2 hrs)
  7. Steps in new drug development (2 hrs)
  8. Laboratory animals (1 hr)
 

SMALL GROUP DISCUSSION:(84 HOURS)

 
  1. Clinical pharmacology charts
  2. Qualitative charts
  3. Experimental pharmacology charts
  4. Problem solving exercises
  5. ADR reporting
  6. Drugs Acting On Skin, Treatment Of Scabies, Drugs For Psoriasis, Drugs For Acne Vulgaris
 

INTEGRATION TOPICS:(15 HOURS)

 
  1. Treatment of Malaria
  2. Treatment of Tuberculosis
  3. Treatment of Bronchial Asthma
  4. Treatment of Pneumonia
  5. Anti-Thyroid Drugs
 
AETCOM (20 hrs)
  1. Bio – ethics – 3 hours(Human – 2 Hrs; Animal – 1 hr )
  2. Computer Assisted Learning (Animal Experiments) – 7 hours
  3. OSPE – 10 Hours
 
Pathology – Green Pharmacology - Brown Microbiology – Red AETCOM – Blue
Forensic Medicine – Purple Community Medicine – Pink General Medicine – Yellow Surgery          - Orange
OG – Yellow on Violet background
 

COIMBATORE MEDICAL COLLEGE

PHASE II MBBS THEORY COMMUNITY MEDICINE
 
 
Month Topic Teaching / learning method
March-April 2021 Concept of health & well being(CM 1.1) Determinants of health(CM 1.2) Indicators of health(CM 1.7)
Concept of disease causation & natural history of disease(CM 1.3, 1.4)
Levels of prevention & modes of intervention(CM1.5)
Dynamics of disease transmission(CM 1.5)
Lecture Lecture Lecture Lecture
 
Lecture Lecture
April-May 2021 Sources of water supply, quality, criteria & standards(CM 3.2)
Hardness of water(CM 3.2) Water treatment(CM 3.2)
Chlorination(CM 3.2)
Air pollution & prevention(CM 3.1) Ventilation , light, noise (CM 3.1)
Small group teaching
 
Self Directed Learning Small group teaching Small group teaching
Small group teaching Small group teaching
May-June 2021 Radiation hazards(CM 3.1)
Meteorological environment & heat stress(CM 3.1) Solid waste management(CM 3.4)
Sewage treatment(CM 3.4)
Housing standards & overcrowding(CM 3.5) Arthropods of medical importance(CM 3.6, 3.7)
Small group teaching Small group teaching Small group teaching Small group teaching
Small group teaching Small group teaching
June-July 2021 Mosquito borne infections & control measures(CM 3.6, 3.7)
Integrated Vector Control(CM 3.7) Insecticides(CM 3.8)
Climate change & health(CM 3.1)
Principles of demography, demographic cycle, vital statistics(CM 9.1)
Fertility related statistics(CM 9.2,9.3)
Lecture
 
Small group teaching Small group teaching Self Directed learning Lecture
 
Lecture
July- August2021 Methods of population control - temporary methods(CM 9.5)
Methods of population control - permanent methods(CM 9.5)
Eligible couple, target couple, Couple Protection Rate, Pearl index(CM 9.4)
Unmet needs of family planning(CM 9.4) Community Need Assessment(CM 9.4)
Sources of Health Information(CM 9.7)
Lecture Lecture
Small group teaching
 
Small group teaching Small group teaching
Lecture
August-
September
Collection & representation of data(CM 6.2)
Sampling methods(CM 6.4)
Small group teaching
Small group teaching
 
2021 Medical ethics(CM 6.4)
Assessment of nutritional status(CM 5.2) Low birth weight & PEM(CM 5.3)
Iron, iodine, Fluorine, Vitamin A deficiency & management(CM 5.3)
Small group teaching Lecture
Lecture
Small group teaching
September- October 2021 Food adulteration , food toxicants & food standards(CM 5.7, 5.8)
Milk & water borne diseases(CM 5.7, 3.3) Methods of health education(CM 4.1) Advantages & disadvantages(CM 4.1)
Topic selection for organizing health education program(CM 4.2)
Preparation for health education activity(CM 4.2)
Small group teaching
 
Lecture
Self Directed learning Self Directed learning Self Directed learning
 
Self Directed learning
October- November 2021 Presentation of health education activity at Community setting(CM 4.2)
Steps in evaluation of health promotion & education program(CM 4.3)
Methods of dietary survey(CM 5.5)
Community Nutritional Programs including ICDS(CM 5.6)
Social problems(CM 2.4)
Definition, Classification, treatment of Hospital waste & related laws(CM 14.1, 14.2, 14.3)
Self Directed learning
Self Directed learning Lecture
Small group teaching
 
Small group teaching Lecture
November- December 2021 Small pox, Chicken pox(CM 8.1) Measles (CM 8.1)
Mumps, Rubella(CM 8.1)
Influenza(CM 8.1)
Diphtheria & Pertussis(CM 8.1) Hepatitis A, B, C, E(CM 8.1) Ameobiasis & food poisoning(CM 8.1) Rickettsial infections(CM 8.1)
Plague (CM 8.1)
Leptospirosis(CM 8.1)
Hospital Acquired infections(CM 8.1) Universal Precautions(CM 8.1)
Self Directed learning Small group teaching Small group teaching Lecture
Small group teaching Lecture
Small group teaching Small group teaching Small group teaching Small group teaching Lecture
Self Directed learning
 
 
Topics covered:
 
  1. Concept of health & disease
  2. Environmental Health problems
  3. Demography & vital statistics
  4. Basic statistics & its application
  5. Nutrition
  6. Principles of health promotion & health education
  7. Nutrition
  8. Relationship of social & behavioral problems to health & disease
  9. Hospital waste management
  10. Epidemiology of Communicable Disease
 
PHASE II MBBS THEORY- FORENSIC      MEDICINE
March-April2021 Theory 1 hour                                                                       SGL
  FM General Information-knowledge of forensic medicine, clinical forensic medicine, ethics FM 1.1 FM General Information- history of forensic medicine FM 1.2
  FM General Information-legal procedure, criminal procedure, IPC, CRPC, IEA, various Courts in
India. FM 1.3, 1.4
FM General InformationSummons, Witness, Cross Examination, Perjury Court stricture FM 1.5 - 1.8
April-May 2021    
  Forensic Pathology Death, Brain stem death, Natural and Unnatural Death, Sudden Natural Death FM 2.1, 2.2, 2.3 Forensic Pathology-Moment of death, Coma and Asphyxia, Presumptionn of death& survivorship, Describe and Discuss Suspended Animation FM 2.5, 2.6,
2.7
  Forensic Pathology-Changes after Death FM 2.8 Forensic Pathology-Putrefaction, adipocere, mummification, time since death FM 2.8, 2.9, 2.10
May-June 2021    
  Forensic Pathology-legal requirements to conduct postmortem examination and procedures to conduct medicolegal postmortem examination FM
2.12, 2.13
Forensic Pathology-Demonstrate respect to the directions of Courts, while appearing as witness for recording of evidence under Oath
FM 2.29
  Forensic Pathology-Have knowledge/awareness of latest decisions/notifications/resolutions/circulars/standing orders related to medicolegal practice issued by Courts / Government authorities etc. FM 2.30  
 
Preservation sample of Autopsy FM 2.35
June-July 2021    
  Forensic Pathology-ability to exchange information by verbal, or non-verbal communication to the peers, family members, law enforcing agency and judiciary FM 2.32 Clinical Forensic Medicine - Identification FM 3.1
  Clinical Forensic Medicine-Identification FM 3.1 Clinical Forensic Medicine- Identification 3.2
July -August 2021    
  Clinical Forensic Medicine-Abortion and MTP Act, Crimincal Abortion, FM 3.27, 3.28 Demonstrate the professionalism while preparing reports in medicolegal situations, interpretation of findings and making inference / opinion, collection, preservation, and dispatch of biological or trace evidences FM 3.32
  Medical Jurisprudence-(Medical Law and ethics)intro, Code of Medical Ethics 2002, Conduct, Etiquette and Ethics in Medical Practice and unethical practices and Dichotomy FM 4.1, 4.2 Medical Jurisprudence-(Medical Law and ethics)- functions and role of Medical Council of India and
State Medical Councils, Medical
Register, Rights privileges of Medical Practitioner, Penal erasure, Infamous conduct, disciplinary committee, Warning notice and penal erasure FM 4.3,
4.4, 4.5
 
August- September
2021
   
  Toxicology: General Toxicology-History FM 8.1 Toxicology: General Toxicologyvarious definition, types of poisons, diagnosis in living and dead FM
8.2, 8.3
  Toxicology: General Toxicology-NDPS Act FM 8.4 Toxicology: General ToxicologyAutopsy in poisoning and sample preservation, common poison encounter in India FM 8.5, 8.6
September- October 2021    
  Toxicology: General Toxicology-Bed-side test, General treatment of poisoning FM 8.7, 8.8 Toxicology: General Toxicologyprocedure of intimation of suspicious cases or actual cases of foul play to the Police, general principles of Analytical Toxicology
FM 8.9, 8.10
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
November - December
2021
   
  Medical Jurisprudence-(Medical Law and ethics)Laws in Relation to medical practice and the duties of a medical practitioner towards patients and society FM 4.6 Medical Jurisprudence-(Medical Law and ethics)-Laws in relation to Medical Practice - HIV, CPA,
NHRC, Communication between doctors, public and media FM 4.7 -
4.10
  Medical Jurisprudence-(Medical Law and ethics)Euthanasia, Stem cell Research, Ethical principles: Respect for autonomy, non-maleficence, beneficence & justice FM 4.11, 4.12, 4.17, 4.22 Medical Jurisprudence-(Medical Law and ethics)-Hippocratic Oath, Modified Declaration of Geneva, Clinical Research, Ethical Committee, Ethical Guidelines FM
4.22, 4.23, 4.25, 4.26, 4.27
 
  Toxicology: Chemical Toxicology-Caustic inorganic and organic poisons FM 9.1 Toxicology: Chemical Toxicology- Phosphorous, iodine, barium, Heavy metals, Ethanol FM 9.2, 9.3,
9.4
October— November 2021    
  Toxicology: Chemical Toxicology-Agricultural poisons, Ammonia, CO, HCN, MIC and Tear Gas
FM 9.5. 9.6
Toxicology: Pharmacological Toxicology-CNS Depressants, Cardiovascular poisons FM 10.1
  Toxicology: Pharmacological Toxicology-Snake Bite FM 11.1 Toxicology: Pharmacological Toxicology-Management of drug abuse, Workman compensation in poisoning FM 12.1, 13.2
 
 
 
 

COIMBATORE MEDICAL COLLEGE

          PHASE 2 MBBS, THEORY SCHEDULE, GENERAL MEDICINE 
 
 
 
S.N
Topic Competencies to be covered
1. Rheumatic Heart Disease IM 1.3 & 1.24.
2 Heart Failure IM 1.2 & 1.4.
3 Ischemic Heart Disease IM 2.1- 2.3.
4 Pneumonia IM 3.1, 3.2 & 3.19.
5 Malaria IM 4.6 ,4.22 & 4.23.
6 Fever of Unknown Origin IM 4.8.
7 Viral Hepatitis IM 5.4 & 5.18.
8 Drug Induced Liver Injury IM 5.7.
9 HIV Disease IM 6.1- 6.6.
10 Diarrheal Disease IM 6.13.
11 Autoimmune Diseases IM 7.1& 7.2.
12 Hypertension IM 8.1-8.3 & 8.7.
13 Anaemia IM 9.1 & 9.2.
14 Renal Failure IM 10.1-10.6.
15 Diabetes Mellitus IM 11.2 & 11.3.
16 Thyroid Dysfunction IM 12.1-12.3.
17 Common Malignancies IM 13.1-13.4.
18 Obesity IM 14.2-14.4
19 Inflammatory Bowel Disease IM 16.15-16.17.
20 Headache & Migraine IM 17.10 -17.12.
21 Stroke IM 18.2.
22 Parkinson’s Disease IM 19.8 & 19.9.
23 Approach to Poisoning IM 21.1,21.2 & 21.6.
24 Hypercalcemia IM 22.1-22.3.
25 Ageing IM 24.18.
26 Zoonotic Diseases IM 25.1-25.3.
 
 
 

COIMBATORE MEDICAL COLLEGE, COIMBATORE PHASE II MBBS, GENERAL SURGERY: THEORY

DAY1 & DAY 2: METABOLIC RESPONSE TO INJURY
 
Homeostasis-Basic concepts; metabolic changes in injury and their mediators. (SU 1.1) Factors that affect the metabolic response to injury. (SU 1.2)
DAY 3 & DAY 4: SHOCK & BLOOD & BLOOD COMPONENTS
 
Shock - Pathophysiology, types & Clinical features. Principles of resuscitation and its appropriate treatment. (SU 2.3)
Communication and counseling of patients and families about the treatment and prognosis of shock with empathy and care (SU 2.3)
DAY5 & DAY 6: BLOOD TRANSFUSION
Blood transfusion- Indications, uses and complications.(SU 3.1)
Observation of blood transfusions. Counseling patients and family/ friends for blood transfusion and blood donation. (SU3.2,3.3)
DAY 7 & DAY 8: WOUND HEALING AND TISSUE REPAIR
Wound healing and factors affecting healing. (SU 5.1)
Wound -various types, plan and its management. Medico legal aspects of wounds (SU 5.3,5.4)
DAY 9 & DAY 10: SURGICAL INFECTIONS
Surgical Infections - Etiology and its pathogenesis.(SU 6.1) Prophylactic and therapeutic management of surgical infection (SU 6.2) DAY 11 & DAY 12: SKIN AND SUBCUTANEOUS TISSUE
Cutaneous and Subcutaneous infections- Pathogenesis, clinical features and management (SU 18.1)
Skin tumors - Classification and its management. (SU18.2)
DAY 13 & DAY 14: BASIC SURGICAL SKILLS
Aseptic techniques, sterilization and disinfection. (SU 14.1)
 
Materials and methods used for surgical wound closure and anastomosis (sutures, knots and needles) (SU 14.3)
DAY 15 & DAY 16: SURGICAL AUDIT AND RESEARCH
Planning and conduct of surgical audit. Principles and steps of clinical research in General Surgery (SU7.2)
DAY 17 & DAY 18: SURGICAL ETHICS
Principles of Ethics as it pertains to General Surgery.(SU8.1)
Professionalism and empathy to the patient undergoing General Surgery. (SU 8.2) Medico-legal issues in surgical practice (SU 8.3)
DAY19 & DAY 20: INVESTIGATION OF SURGICAL PATIENT
Biochemical, Microbiological, Pathological, Imaging investigations and interpretation of the investigative data in a surgical patient. (SU 9.1)
Communication of the results of surgical investigations and counseling the patient appropriately (SU 9.3)
Gastrointestinal endoscopy and tissue and molecular diagnosis (SU 9.1)
DAY 21& DAY 22: NUTRITION AND FLUID THERAPY
Malnutrition-Causes  and   consequences   in   surgical   patient.   Fluid   and   electrolyte management in surgical patient. (SU 12.1, 12.2)
Methods of providing nutritional support and their complications (SU 12.3)
DAY 23: PRE, INTRA AND POST- OPERATIVE MANAGEMENT.
Principles of perioperative management in common surgical procedures. Principles of perioperative management in high risk surgical patient (SU 10.1)
DAY 24 & DAY 25: ANAESTHESIA AND PAIN MANAGEMENT
Principles of Preoperative assessment. Principles of general, regional, and local Anesthesia. Indications and principles of day care General Surgery. (SU 11.1,11.2,11.4)
Principles of safe General Surgery. Principles of providing post-operative pain relief and management of chronic pain (SU 11.5, 11.6)
 
 
 
 
 
 
 
COIMBATORE MEDICAL COLLEGE, COIMBATORE
 
              PHASE 2 MBBS, OBSTETRICS & GYNECOLOGY THEORY                 
 
S. NO TOPIC HORIZONTAL
INTEGRATION
VERTICAL
INTEGRATION
 
1
 
Definition, Classification, etiology, investigations and treatment of anemia in pregnancy (OG 12.2)
 
PATHOLOGY
 
 
2
 
Effects and complications of anemia in pregnancy (OG 12.2)
   
 
3
 
Definition, classification of hypertension; etiology and pathogenesis of gestational hypertension (OG 12.1)
   
 
 
MEDICINE
 
 
4
 
 
Complications of Gestational hypertension (OG 12.1)
   
 
 
 
5
 
 
Definition, classification, pathogenesis and management of Gestational diabetes mellitus. (OG 12.3)
   
 
6
 
Complications and effects of diabetes in pregnancy on the mother and the baby (OG 12.3)
   
 
 
7
 
 
Asymptomatic bacteriuria; management of UTI in pregnancy; different microbes responsible for UTI in pregnancy (OG 12.5)
 
 
MICROBIOLOGY
 
 
8
 
Effects of HIV in pregnancy and management (OG 27.3)
   
 
 
 
9
 
Physiological changes in cardio vascular system in pregnancy; Management of heart disease in pregnancy and labor (OG 12.4)
   
 
 
PHYSIOLOGY
 
10.
 
Etiology, differential diagnosis and management of jaundice complicating pregnancy (OG 12.6)
   
 
11.
 
Iso immunization in pregnancy (OG 12.8)
  PEDIATRICS
12. Gynecological examination (OG 35.1,
35.2)
   
13. Diseases of the vagina and vulva (OG 22.1, 22.2)    
 
14.
 
Anatomy of female genital tract; Malformations of female genital tract (OG 2.1, AN 52.8)
   
15. Tuberculosis of the female genital tract(OG 27.2)    
 
 
16. Sexually transmitted diseases (OG 27.1)    
 
17.
 
Physiology of menstruation (AN 77.1,
77.2, OG 3.1)
   
PHYSIOLOGY
 
18.
 
Multiple pregnancy (OG 11.1)
   
 
19.
 
Menopause (OG 32.1, PY 9.11))
   
 
20.
 
Hormonal therapy in women (OG 32.1)
 
PHARMACOLOGY
 
 
21.
 
Abortion (OG 1.3,9.1, 9.2)
   
 
22.
 
Leucorrhoea (OG 22.1,
22.2)
   
23. Benign tumors of uterus
 
(PA 30.3)
PATHOLOGY  
 
24.
 
Vaccination in pregnancy (OG 8.7)
   
 
 
 
 
 
 
COIMBATORE MEDICAL COLLEGE, COIMBATORE PANDEMIC MODULE FOR PHASE 2 MBBS
NUMBER OF HOURS: 28
 
DATE 9 AM TO 10 AM 10 AM TO 11 AM 11 AM TO 12
NOON
12 NOON TO 1 PM
5.3.2021 Infection control – Introduction Pandemic
diseases(MI)
Overview of air borne Infections; precautions to
tackle them (MI)
Overview of Contact infections; Precautions to
tackle them (MI)
Infection control committee: Scope, roles and
responsibilities (MI)
6.3.2021 Overview of Emerging infections (CM) Overview of Re- emerging infections (CM) Role of health care system in the early identification of new infections (
CM)
Role of the health care system in the control of new infections (CM)
8.3.2021 Surveillance of emerging and re- emerging infections; sources of epidemiological data and interpretation (CM) Area mapping, Analysis of geographic distribution and case clustering (CM) Microbiological samples to be collected in various infections and Pandemics (MI) Guidelines for collection, handling and disposal of infected samples Demonstration of Triple layer packing and transport (MI)
9.3.2021 Microbial culture methods in the diagnosis of various infections (MI) Serological tests in the diagnosis of various infections and Pandemics Introduction, Principles of various serological tests in detail (MI) Molecular methods in the diagnosis of various infections and Pandemics(MI)
10.3.2021 The spectrum of Dengue illness& its diagnosis: Dengue Fever with warning signs, Dengue Hemorrhagic Fever, Dengue Shock
Syndrome (CM)
Treatment, complications and prevention of Dengue Hemorrhagic Fever and Dengue Shock Syndrome
(IM)
An overview of H1N1, its management and complications (IM) An overview of Covid 19, treatment and complications (CT)
11.3.2021 Vaccination, Immunization, Seroconversion; Live vaccines, killed vaccines, sub unit vaccines, AEFI and its
reporting (PE)
Vaccine trials (CM) Development of Covid 19 vaccine (BIO) Preventive strategies in epidemics and pandemics (CM)
12.3.2021 Drug trials (PH) Antiviral therapy of H1N1 infection: (PH) Overview of drugs against Novel Corona virus:
Favipiravir,
Scope for Research in Epidemics and Pandemics (CM)
 
      Remdesivir and
others (PH)
 
 

Designed & Developed by

This site can be best viewed in 1024x768 screen resolution.